Pro-Dex Inc (co) PDEX Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$58.26 down $1.76, 2.93% at close Oct 16
Last close · Previous close $60.02
- Market cap
- At the Oct 16 close
- P/E ratio
- 14.31On last 12 months’ EPS
- Diluted EPS
- $4.07Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$58.26down $1.76, 2.93%Fri, Oct 16 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$60.02Oct 15
- Volume21.87KOct 16 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume54.82KLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $25.25 to $77.00; now $58.26
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Oct 16 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
PDEX beat the S&P 500 in 5 of 7 periods.
| Period | PDEX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PDEX: down 18.9% S&P 500: up 1.5% | PDEX trailed the S&P 500 by 20.4 percentage points Trailed |
| 3M | PDEX: down 1.4% S&P 500: up 1.9% | PDEX trailed the S&P 500 by 3.3 percentage points Trailed |
| YTD | PDEX: up 51.4% S&P 500: up 12.8% | PDEX beat the S&P 500 by 38.6 percentage points Beat |
| 1Y | PDEX: up 143.7% S&P 500: up 16.8% | PDEX beat the S&P 500 by 126.9 percentage points Beat |
| Long term | ||
| 3Y | PDEX: up 257.9% S&P 500: up 81.5% +53.0% vs +22.0% a year | PDEX beat the S&P 500 by 176.4 percentage points Beat |
| 5Y | PDEX: up 126.6% S&P 500: up 83.1% +17.8% vs +12.9% a year | PDEX beat the S&P 500 by 43.5 percentage points Beat |
| 10Y | PDEX: up 1,163.8% S&P 500: up 319.6% +28.9% vs +15.4% a year | PDEX beat the S&P 500 by 844.2 percentage points Beat |
$10,000 invested in PDEX 10 years ago (Oct 14, 2016) would be worth about $126,377 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $41,964.
PDEX beat the S&P 500 in 5 of 7 periods.
| Period | PDEX and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | PDEX: down 18.9% S&P 500: up 1.2% | PDEX trailed the S&P 500 by 20.1 percentage points Trailed |
| 3M | PDEX: down 1.4% S&P 500: up 1.7% | PDEX trailed the S&P 500 by 3.1 percentage points Trailed |
| YTD | PDEX: up 51.4% S&P 500: up 11.9% | PDEX beat the S&P 500 by 39.5 percentage points Beat |
| 1Y | PDEX: up 143.7% S&P 500: up 15.5% | PDEX beat the S&P 500 by 128.2 percentage points Beat |
| Long term | ||
| 3Y | PDEX: up 257.9% S&P 500: up 75.0% +53.0% vs +20.5% a year | PDEX beat the S&P 500 by 182.9 percentage points Beat |
| 5Y | PDEX: up 126.6% S&P 500: up 71.2% +17.8% vs +11.4% a year | PDEX beat the S&P 500 by 55.4 percentage points Beat |
| 10Y | PDEX: up 1,163.8% S&P 500: up 258.1% +28.9% vs +13.6% a year | PDEX beat the S&P 500 by 905.7 percentage points Beat |
$10,000 invested in PDEX 10 years ago (Oct 14, 2016) would be worth about $126,377 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $35,813.
All-time high
$73.41
Closing high on . Now 20.6% below that record.
Split-adjusted daily closes since Aug 18, 1995.
Stock splits
1
1-for-3 on . Share counts adjust after each split.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q4 FY26, the quarter ended Jun 30, 2026. “Last 12 months” means the four quarters from Jul 1, 2025 to Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026.
Revenue and net income
Last 12 months, with the change from the 12 months before
- Revenue
- $77.55Mup 16.4%
- Net income
- $13.66Mup 52.2%
- Diluted EPS
- $4.07up 52.4%
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q1 FY25 (Sep 30, 2024) | $14.89M | $2.47M | $0.75 |
| Q2 FY25 (Dec 31, 2024) | $16.79M | $2.04M | $0.61 |
| Q3 FY25 (Mar 31, 2025) | $17.41M | $3.28M | $1.00 |
| Q4 FY25 (Jun 30, 2025) | $17.49M | $1.20M | $0.31 |
| Q1 FY26 (Sep 30, 2025) | $18.53M | $4.68M | $1.40 |
| Q2 FY26 (Dec 31, 2025) | $18.66M | $2.19M | $0.66 |
| Q3 FY26 (Mar 31, 2026) | $19.95M | $3.94M | $1.23 |
| Q4 FY26 (Jun 30, 2026) | $20.41M | $2.86M | $0.78 |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY22 (Jun 30, 2022) | $42.04M | $4.57M | $1.21 |
| FY23 (Jun 30, 2023) | $46.09M | $7.07M | $1.95 |
| FY24 (Jun 30, 2024) | $53.84M | $2.13M | $0.60 |
| FY25 (Jun 30, 2025) | $66.59M | $8.98M | $2.67 |
| FY26 (Jun 30, 2026) | $77.55M | $13.66M | $4.12 |
Margins
- Gross 31.4%
- Operating 16.8%
- Net 17.6%
The percentages above the chart cover the last 12 months; the lines show each quarter. What margins tell you
Cash flow
- $6.76MLast 12 months
Cash from operations minus capital spending: the cash left after the business maintains and grows its assets.
FCF = Operating cash flow − Capital spendingFree cash flow - Operating cash flow$7.24MLast 12 months
- Capital spending$483.00KLast 12 months
- 8.7%Last 12 months
Free cash flow as a share of revenue, both over the last 12 months.
Shareholder returns
- $3.35MLast 12 months
Cash spent repurchasing shares, net of shares issued. Buybacks shrink the share count, so each remaining share owns more of the company.
- Dividends paid$0.00Last 12 months
- Total returned$3.35MLast 12 months
50% of free cash flow
Balance sheet
- $9.85MAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$18.10MAs of Jun 30, 2026
- Net debt$8.25MAs of Jun 30, 2026
- 4.10As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 0.38As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
- 6 of 9Last 12 months
vs the 12 beforeA 0–9 checklist from accounting professor Joseph Piotroski. Each test compares the last 12 months with the 12 months before and scores a point if it passes. 8–9 is strong; 0–2 is weak.
- ✓Net income was positive: passed
- ✓Operating cash flow was positive: passed
- ✓Return on assets improved: passed
- ✗Operating cash flow exceeded net income: not passed
- ✗Long-term debt fell relative to assets: not passed
- ✓Current ratio improved: passed
- ✓Share count didn’t rise: passed
- ✓Gross margin improved: passed
- ✗Asset turnover (revenue ÷ assets) improved: not passed
- 31.1%Last 12 months
Over the last 12 months, Pro-Dex Inc (co)’s net income was 31.1% of its shareholders’ equity (averaged over the last four quarter-ends). It describes the past year, not an expected return.
ROE = Net income (last 12 months) ÷ Average equityReturn on equity - 19.8%Last 12 months
Over the last 12 months, Pro-Dex Inc (co)’s net income was 19.8% of its total assets (averaged over the last four quarter-ends): what the business earned on everything it owns.
ROA = Net income (last 12 months) ÷ Average total assets
About Pro-Dex Inc (co)
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. Pro-Dex also manufactures and sells rotary air motors to a wide range of industries. Pro-Dex's products are found in hospitals and medical engineering labs around the world.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- California, USA
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
PDEX news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
PDEX stock FAQ
What is PDEX stock’s price today?
Pro-Dex Inc (co) (PDEX) traded at $58.26 at the close on , down $1.76 (2.93%) from the previous close of $60.02. Over the past 52 weeks it has traded between $25.25 and $77.00.
If you invested $1,000 in PDEX 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in PDEX on would be worth about $12,638 at the close on , a total return of +1,163.8%. The same $1,000 would be worth $2,266 if invested five years ago, $2,437 if invested one year ago, $14,712 if invested 20 years ago, and $5,649 if invested 30 years ago. Past performance doesn’t predict future returns.
What is PDEX’s P/E ratio?
PDEX trades at 14.3 times its diluted earnings over the four quarters to ($4.07 per share), at the close. (How the P/E ratio works.)
How much revenue does Pro-Dex Inc (co) make?
Pro-Dex Inc (co) reported $77.5 million of revenue over the four quarters to , up 16.4% from the twelve months before. In its latest quarter (Q4 FY26, ended ) revenue was $20.4 million, up 16.6% from a year earlier.
Is Pro-Dex Inc (co) profitable?
Yes. Pro-Dex Inc (co) earned $13.7 million of net income over the four quarters to , a net margin of 17.6%, and its operating margin was 16.8% (what margins tell you).
What are PDEX’s earnings per share?
PDEX’s diluted earnings per share were $4.07 over the four quarters to , compared with $2.67 in the twelve months before. The latest quarter (Q4 FY26) brought $0.78 per share, against $0.31 a year earlier (how EPS works).
Does PDEX pay a dividend?
Pro-Dex Inc (co) hasn’t paid a dividend in the last twelve months.
What is PDEX’s 52-week high and low?
Over the past 52 weeks PDEX has traded as low as $25.25 and as high as $77.00. At $58.26 at the close on , it is 24.3% below that high and 130.8% above the low.
What is PDEX’s all-time high?
PDEX’s highest closing price was $73.41 on , adjusted for stock splits. At $58.26 at the close on , it is 20.6% below that record.
Has PDEX stock ever split?
Yes, once: 1-for-3 on .
How has PDEX stock performed?
Including dividends and measured to the close on , PDEX has returned +51.4% so far this year and +143.7% over the past year, and +126.6% over five years (+17.8% a year). Over the same periods the S&P 500, measured by SPY, returned +12.8%, +16.8% and +83.1%. Past performance doesn’t predict future returns.
What sector and industry is Pro-Dex Inc (co) in?
Pro-Dex Inc (co) is in the Healthcare sector and the Medical Instruments & Supplies industry, and is headquartered in California, USA.
What exchange does PDEX trade on?
Pro-Dex Inc (co) trades on the Nasdaq under the ticker symbol PDEX. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.